PDCD1 and esophageal squamous cell carcinoma: In this study, we undertake the scRNA-seq assay to uncover the key role of intra-tumoral cell type composition and their relationship to differential pathological responses to neoadjuvant therapy with PD-1 monoclonal antibodies plus chemotherapy in ESCC.